1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Mental Health Market Trends
  5. > Mental Health Analysis & Statistics 2022 - United Kingdom (p2)

Mental Health Analysis & Statistics 2022 - United Kingdom (p2)

31-60 of about 100 reports

Wilson’s Disease (WD) – Epidemiology Forecast – 2030

  • $ 3750
  • January 2021
  • 80 pages

‘Wilson’s Disease (WD) – Epidemiology Forecast – 2030’ report delivers an in-depth understanding of and historical and forecasted epidemiology of Wilson’s disease (WD) in the United States, ...

  • Spain
  • Japan
  • Neurological Disorder
  • Industry analysis

Adrenoleukodystrophy (ALD) - Epidemiology Forecast to 2030

  • $ 3750
  • December 2020
  • 60 pages

‘Adrenoleukodystrophy (ALD) - Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted Adrenoleukodystrophy epidemiology in the 7MM, i.e., ...

  • France
  • Germany
  • Neurological Disorder
  • Epidemiology
  • Industry analysis

Chemotherapy Induced Peripheral Neuropathy (CIPN) - Epidemiology Forecast–2030

  • $ 3750
  • December 2020
  • 55 pages

‘Chemotherapy Induced Peripheral Neuropathy (CIPN) - Epidemiology Forecast–2030’ report delivers an in-depth understanding of the CIPN, historical and forecasted epidemiology as well as the CIPN ...

  • United States
  • Japan
  • Epidemiology
  • Neurological Disorder
  • Industry analysis

West Syndrome - Epidemiology Forecast - 2030

  • $ 3750
  • September 2020
  • 100 pages

‘West Syndrome - Epidemiology Forecast–2030’ report delivers an in-depth understanding of the disease, historical and forecasted West Syndrome epidemiology in the United States, EU5 (Germany, Spain, ...

  • United States
  • Spain
  • Epidemiology
  • Neurological Disorder
  • Industry analysis

West Syndrome - Epidemiology Forecast - 2030

  • $ 3750
  • September 2020
  • 100 pages

‘West Syndrome - Epidemiology Forecast–2030’ report delivers an in-depth understanding of the disease, historical and forecasted West Syndrome epidemiology in the United States, EU5 (Germany, Spain, ...

  • United States
  • Spain
  • Epidemiology
  • Neurological Disorder
  • Industry analysis

AAV2/8 LSPHGAA - Emerging Drug Insight and Market Forecast – 2030

  • $ 3250
  • September 2020
  • 50 pages

“AAV2/8 LSPHGAA - Emerging Drug Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product for Pompe Disease in 7 Major Markets. A detailed picture ...

  • Europe
  • Japan
  • Neurological Disorder
  • Research And Development
  • Industry analysis
  • Health Expenditure

AT845 - Emerging Drug Insight and Market Forecast – 2030

  • $ 3250
  • September 2020
  • 50 pages

“AT845 - Emerging Drug Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product for Pompe Disease in 7 Major Markets. A detailed picture of ...

  • Europe
  • Japan
  • Neurological Disorder
  • Research And Development
  • Industry analysis
  • Health Expenditure

AVR RD 01 - Emerging Drug Insight and Market Forecast – 2030

  • $ 3250
  • September 2020
  • 50 pages

“AVR RD 01 - Emerging Drug Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product for Fabry Disease in 7 Major Markets. A detailed picture ...

  • Europe
  • World
  • Neurological Disorder
  • Research And Development
  • Industry analysis
  • Health Expenditure

FLT190 - Emerging Drug Insight and Market Forecast – 2030

  • $ 3250
  • September 2020
  • 50 pages

“FLT190 - Emerging Drug Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product for Fabry Disease in 7 Major Markets. A detailed picture of ...

  • Europe
  • Japan
  • Neurological Disorder
  • Therapy
  • Industry analysis
  • Health Expenditure

Lenti-D- Emerging Drug Insight and Market Forecast – 2030

  • $ 3250
  • September 2020
  • 50 pages

“Lenti-D- Emerging Drug Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product for Cerebral Adrenoleukodystrophy (CALD) in 7 Major Markets. ...

  • Europe
  • Japan
  • Research And Development
  • Neurological Disorder
  • Industry analysis
  • Health Expenditure

SPK 3006 - Emerging Drug Insight and Market Forecast – 2030

  • $ 3250
  • September 2020
  • 50 pages

“SPK 3006 - Emerging Drug Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product for Pompe Disease in 7 Major Markets. A detailed picture ...

  • Europe
  • World
  • Neurological Disorder
  • Research And Development
  • Industry analysis
  • Health Expenditure

ST-920 - Emerging Drug Insight and Market Forecast – 2030

  • $ 3250
  • September 2020
  • 50 pages

“ST-920 - Emerging Drug Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product for Fabry Disease in 7 Major Markets. A detailed picture of ...

  • Europe
  • Japan
  • Neurological Disorder
  • Research And Development
  • Industry analysis
  • Health Expenditure

Alcohol Use Disorder - Epidemiology forecast- 2030

  • $ 3750
  • September 2020
  • 118 pages

‘Alcohol Use Disorder- Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical, and forecasted Alcohol Use Disorder epidemiology in the 7MM, i.e., the United ...

  • United States
  • Japan
  • Addiction Disorder
  • Industry analysis
  • Alcohol Excessive Use

Lumizyme (alglucosidase alfa) - Drug Insight and Market Forecast - 2030

  • $ 2750
  • August 2020
  • 80 pages

Overview “Lumizyme (alglucosidase alfa) - Drug Insight and Market Forecast – 2030” report outlays comprehensive insights of the product indicated for the treatment of its approved condition. A detailed ...

  • Europe
  • Japan
  • Clinical Trial
  • Neurological Disorder
  • Industry analysis
  • Health Expenditure

Idebenone - Drug Insight and Market Forecast - 2030

  • $ 3250
  • August 2020
  • 80 pages

Overview “Idebenone - Emerging Insight and Market Forecast – 2030” report outlays comprehensive insights of the product indicated for the treatment of its approved condition. A detailed picture ...

  • Europe
  • World
  • Clinical Trial
  • Neurological Disorder
  • Industry analysis
  • Health Expenditure

Lennox Gastaut Syndrome - Epidemiology Forecast–2030

  • $ 3750
  • July 2020
  • 100 pages

‘Lennox Gastaut Syndrome (LGS) - Epidemiology Forecast - 2030’ report delivers an in-depth understanding of the Lennox Gastaut Syndrome (LGS), historical and forecasted epidemiology in the United States, ...

  • United States
  • Spain
  • Neurological Disorder
  • Industry analysis

Dravet Syndrome Epidemiology Forecast to 2030

  • $ 3750
  • July 2020
  • 100 pages

‘Dravet Syndrome – Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted Dravet Syndrome epidemiology in the 7MM, i.e., the United States, ...

  • Japan
  • United States
  • Neurological Disorder
  • Industry analysis

Dementia with Diabetes - Epidemiology Forecast to 2030

  • $ 3750
  • July 2020
  • 90 pages

‘Dementia with Diabetes—Epidemiology Forecast–2030’ report delivers an in-depth understanding of the disease, historical and forecasted Dementia with Diabetes epidemiology in the United States, ...

  • United States
  • United Kingdom
  • Dementia
  • Industry analysis
  • Dementia Prevalence

Angelman Syndrome Epidemiology Forecast to 2030

  • $ 3750
  • July 2020
  • 100 pages

‘Angelman Syndrome - Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted Angelman Syndrome epidemiology in the 7MM, i.e., the United States, ...

  • Japan
  • United States
  • Neurological Disorder
  • Industry analysis

Treatment-resistant depression (TRD) - Epidemiology Forecast - 2030

  • $ 3750
  • June 2020
  • 100 pages

‘Treatment-resistant depression (TRD)– Epidemiology Forecast—2030’ report delivers an in-depth understanding of the Treatment-resistant depression, historical and forecasted epidemiology in the ...

  • Italy
  • Spain
  • Depression
  • Therapy
  • Industry analysis

Frontotemporal Dementia (FTD)- Epidemiology Forecast to 2030

  • $ 3750
  • May 2020
  • 100 pages

‘Frontotemporal Dementia (FTD) - Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical & forecasted epidemiology of Frontotemporal Dementia in the United ...

  • United States
  • World
  • Neurological Disorder
  • Epidemiology
  • Industry analysis

Pompe Disease - Epidemiology Forecast to 2030

  • $ 3750
  • May 2020
  • 100 pages

‘Pompe Disease (PD) - Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical & forecasted epidemiology of Pompe Disease in the United States, EU5 (Germany, ...

  • World
  • Spain
  • Neurological Disorder
  • Industry analysis

Duchenne Muscular Dystrophy - Epidemiology Forecast to 2030

  • $ 3750
  • April 2020
  • 100 pages

‘Duchenne Muscular Dystrophy (DMD) - Epidemiology Forecast–2030’ report delivers an in-depth understanding of the disease, historical and forecasted Duchenne Muscular Dystrophy (DMD) epidemiology ...

  • United States
  • Spain
  • Neurological Disorder
  • Industry analysis

Casimersen - Emerging Insight and Market Forecast – 2030

  • $ 3250
  • April 2020
  • 60 pages

“Casimersen - Emerging Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product for Duchenne Muscular Dystrophy in 7 Major Markets. A detailed ...

  • Europe
  • Japan
  • Neurological Disorder
  • Research And Development
  • Industry analysis
  • Health Expenditure

Idebenone - Emerging Insight and Market Forecast – 2030

  • $ 3250
  • April 2020
  • 60 pages

“Idebenone - Emerging Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product for Duchenne Muscular Dystrophy in 7 Major Markets. A detailed ...

  • Europe
  • Japan
  • Neurological Disorder
  • Research And Development
  • Industry analysis
  • Health Expenditure

PF-06939926 - Emerging Insight and Market Forecast – 2030

  • $ 3250
  • April 2020
  • 60 pages

“PF-06939926 - Emerging Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product for Duchene muscular dystrophy (DMD) in 7 Major Markets. A ...

  • Europe
  • Japan
  • Neurological Disorder
  • Research And Development
  • Industry analysis
  • Health Expenditure

SRP-9001 - Emerging Insight and Market Forecast – 2030

  • $ 3250
  • April 2020
  • 60 pages

“SRP-9001 - Emerging Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product for Duchene muscular dystrophy (DMD) in 7 Major Markets. A detailed ...

  • Europe
  • Japan
  • Neurological Disorder
  • Therapy
  • Industry analysis
  • Health Expenditure

Vamorolone - Emerging Insight and Market Forecast – 2030

  • $ 3250
  • April 2020
  • 60 pages

“Vamorolone - Emerging Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product for Duchenne Muscular Dystrophy in 7 Major Markets. A detailed ...

  • Europe
  • Japan
  • Neurological Disorder
  • Research And Development
  • Industry analysis
  • Health Expenditure

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)– Epidemiology Forecast—2030

  • $ 3750
  • March 2020
  • 97 pages

‘Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)– Epidemiology Forecast—2030’ report delivers an in-depth understanding of the CIDP, historical and forecasted epidemiology in the United ...

  • United States
  • Spain
  • Neurological Disorder
  • Industry analysis

Diabetic Peripheral Neuropathy (DPN) - Epidemiology Forecast-2030

  • $ 3750
  • February 2020
  • 80 pages

‘Diabetic Peripheral Neuropathy (DPN) - Epidemiology Forecast-2030’ report deliver an in-depth understanding of the disease, historical & forecasted epidemiology trends of Diabetic Peripheral Neuropathy ...

  • Spain
  • Japan
  • Neurological Disorder
  • Industry analysis

Reportlinker.com © Copyright 2022. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on